Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Corgentech treatment fails trial Shares plunge after company says its vein graft treatment failed to show benefit in late-stage test. CHICAGO (Reuters) - Biotechnology company Corgentech Inc.
